文献速递腹部介入CT

CT动脉减影图像对经导管动脉化疗栓塞治疗肝细胞癌的LI-RADS治疗反应分类的附加价值

Added Value of CT Arterial Subtraction Images in Liver Imaging Reporting and Data System Treatment Response Categorization for Transcatheter Arterial Chemoembolization-Treated Hepatocellular Carcinoma.
PubMed 文献 · Invest Radiol · 2021-01-01

本回顾性研究纳入115例经TACE治疗的肝细胞癌患者共151个病灶,评估在常规多期CT基础上增加动脉减影图像对LI-RADS v2018治疗反应分类的影响。结果显示,加用减影图像后LR-TR存活类别的敏感度从53.7%-56.7%提高至88.1%-89.6%(P<0.002),特异度无显著下降,诊断信心提高,观察者间一致性极好。

要点

  • 常规多期CT的LR-TR存活类别特异度高但敏感度不足,加用动脉减影图像可显著提高敏感度。
  • 减影图像质量大多良好至完美(98.7%),观察者间一致性良好(κ=0.71),无不可诊断图像。
  • 加用减影图像后LR-TR存活被误分类为无存活的比例从31.3%-34.3%降至9%-10.4%。

关键影像表现/征象

  • 减影图像质量大多良好至完美(98.7%),观察者间一致性良好(κ=0.71),无不可诊断图像。
  • 仅多期CT图像集(集1)中LR-TR存活类别的敏感度为53.7%-56.7%,特异度为96.4%-98.8%。
  • 联合减影图像集(集2)中LR-TR存活类别的敏感度为88.1%-89.6%(P<0.002),特异度为94%-95.2%(P>0.13)。
  • 集1中31.3%-34.3%的存活肝细胞癌被误分类为LR-TR无存活,集2中为9%-10.4%。
  • LR-TR不确定类别在集2中较少(1.3%),集1中为6.6%-7.9%;集2诊断信心略高(3.4±0.8 vs 3.8±0.5)。

诊断标准与关键数值

  • LR-TR存活类别的敏感度:集1为53.7%-56.7%,集2为88.1%-89.6%(P<0.002)。
  • LR-TR存活类别的特异度:集1为96.4%-98.8%,集2为94%-95.2%(P>0.13)。
  • 观察者间一致性:集1 κ=0.85,集2 κ=0.97;减影图像质量 κ=0.71。

临床应用与阅片要点

  • 在TACE治疗后肝细胞癌的LI-RADS治疗反应分类中,加用动脉减影图像可提高存活肿瘤检出的敏感度并提高诊断信心。
  • 常规多期CT上LR-TR存活类别特异度高但敏感度不足,减影图像有助于减少存活肿瘤被误分类为无存活。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to assess the benefit of adding arterial subtraction images from computed tomography (CT) to the Liver Imaging Reporting and Data System (LI-RADS) v2018 treatment response (LR-TR) categorization in patients treated with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: This retrospective study included 115 patients with 151 HCCs treated by TACE using an emulsion of doxorubicin and iodized oil who underwent multiphasic CT protocol that additionally generated arterial subtraction images based on nonrigid anatomic correction algorithm. Of 151 HCCs, 67 (44.4%) were viable and 84 (55.6%) were nonviable. Two independent readers assessed the per-lesion LR-TR categories in set 1 of multiphasic CT images alone and set 2 including both set 1 and CT arterial subtraction images, besides diagnostic confidence, and the quality of subtraction images. The sensitivity and specificity of LR-TR viable category between the sets were compared using the generalized estimating equation. Interobserver agreements of LR-TR categorization in each set and the quality of subtraction images were assessed by Cohen κ.

RESULTS: The quality of subtraction images was mostly good to perfect (98.7%) with good interobserver agreement (κ = 0.71), and none were nondiagnostic. For detecting viable HCC, LR-TR viable category showed sensitivity of 53.7% to 56.7% and specificity of 96.4% to 98.8% in set 1. In comparison, set 2 showed significantly higher sensitivity of 88.1% to 89.6% (P < 0.002) and equivalent specificity of 94% to 95.2% (P > 0.13) for the same category. In sets 1 and 2, 31.3% to 34.3% and 9% to 10.4% of viable HCC were miscategorized as LR-TR nonviable, respectively. LR-TR equivocal category was less assigned in set 2 (1.3%) than in set 1 (6.6%-7.9%). Set 2 showed slightly higher level of confidence for LR-TR categorization compared with set 1 (3.4 ± 0.8 vs 3.8 ± 0.5). Interobserver agreement was excellent in both sets (κ = 0.85 in set 1 and 0.97 in set 2).

CONCLUSIONS: The LR-TR viable category is highly specific but inadequately sensitive for detecting viable tumor in TACE-treated HCC on conventional multiphasic CT. Adding arterial subtraction images to the conventional CT images significantly increases sensitivity without compromising the specificity and improves the diagnostic confidence of LR-TR viable category.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Huh J, Kim B, Lee JH, et al. Added Value of CT Arterial Subtraction Images in Liver Imaging Reporting and Data System Treatment Response Categorization for Transcatheter Arterial Chemoembolization-Treated Hepatocellular Carcinoma. Invest Radiol. 2021. PMID: 33405431. doi:10.1097/RLI.0000000000000714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。